Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science
Link
http://link.springer.com/content/pdf/10.1007/s40005-021-00527-x.pdf
Reference94 articles.
1. Angell TE, Lechner MG, Jang JK, LoPresti JS, Epstein AL (2014) MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro. Clin Cancer Res 20(23):6034–6044. https://doi.org/10.1158/1078-0432.Ccr-14-0879
2. Berraondo P, Sanmamed MF, Ochoa MC et al (2019) Cytokines in clinical cancer immunotherapy. Br J Cancer 120(1):6–15. https://doi.org/10.1038/s41416-018-0328-y
3. Bladergroen BA, Meijer CJ, ten Berge RL et al (2002) Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99(1):232–237. https://doi.org/10.1182/blood.v99.1.232
4. Boyiadzis MM, Dhodapkar MV, Brentjens RJ et al (2018) Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance. J Immunother Cancer 6(1):137. https://doi.org/10.1186/s40425-018-0460-5
5. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy;Pharmaceutics;2024-03-01
2. Nano-based vaccination and their administration routes in cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024
3. Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy;Journal of Pharmaceutical Investigation;2023-12-01
4. Alum-tuned hyaluronic acid-based hydrogel with immune checkpoint inhibition for immunophoto therapy of cancer;Journal of Controlled Release;2023-10
5. Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy;Nature Communications;2023-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3